Perceptive Discovery Launches FIBRE Consortium with Pfizer, Lantheus, and Lumina to Advance Imaging Biomarkers in Fibrotic Diseases

Perceptive Discovery, a global leader in molecular and functional imaging research, today announced the launch of the FIBRE (Fibrosis Imaging Biomarker R...

June 23, 2025 | Monday | News
Harbour BioMed and Otsuka Enter $670M+ Global Agreement Across Asia, US, and Europe to Advance Bispecific T-Cell Engager for Autoimmune Diseases

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology ...

June 23, 2025 | Monday | News
BIO 2025 Closes in Boston with Global Biotech Leaders Uniting for a New Era of Innovation and Impact

The BIO International Convention 2025 concluded in Boston with an exceptional display of biopharmaceutical innovation, regulatory dialogue, investment di...

June 20, 2025 | Friday | News
Symbiotic.blue Launches in the UK to Redesign Drug Discovery with Brain-Inspired AI

Symbiotic.blue, the UK’s newest Techbio company has launched to innovate a next-generation artificial intelligence-driven drug discovery (AIDD) pla...

June 20, 2025 | Friday | News
Draig Therapeutics Launches with $140M to Advance Novel Neuropsychiatric Treatments

Clinical-stage company led by world-class team targeting core neurotransmission pathways underlying neuropsychiatric disorders with a rich pipeline of ...

June 19, 2025 | Thursday | News
QIAGEN and Incyte Partner to Develop Global Companion Diagnostic Panel for CALR-Mutant Blood Cancers

QIAGEN N.V.  and Incyte  announced a new global collaboration to develop a novel diagnostic panel to support Incyte’s extensive portfolio...

June 16, 2025 | Monday | News
Volta Labs Launches Automated Library Prep App for Oxford Nanopore on Callisto System

Volta Labs, a genomics applications company,  announced the launch of its Library Prep App for Oxford Nanopore LSK114 on the Callisto™ Sample ...

June 13, 2025 | Friday | News
Sinovac’s Showdown: Board Fights Back Against Dissident Slate as $55/Share Dividend Hangs in Balance

Sinovac Biotech Ltd. (NASDAQ: SVA), a prominent player in China's biopharmaceutical sector, has entered a defining phase in its corporate history. As the...

June 13, 2025 | Friday | Reports
Angelini Ventures Invests in Elkedonia to Advance First-in-Class Neuroplastogen for Treatment-Resistant Depression

Investment supports the development of first-in-class, non-addictive, non-hallucinogenic molecules with a non-synaptic target, differentiated from existi...

June 12, 2025 | Thursday | News
EDETEK Partners with Capgemini to Accelerate AI-Driven Digital Transformation in Clinical Development

  EDETEK Inc., a global provider of leading AI-driven clinical development platforms and services, has engaged Capgemini to support its ongoing advan...

June 11, 2025 | Wednesday | News
Yoneda Labs and Symeres Boost Cross-Coupling Reaction Yields from 30 to Over 90 Percent Using AI-Driven Optimization

Yoneda Labs, a leader in computational tools for reaction optimization, has successfully collaborated with Symeres, a leading transatlantic, small molecule...

June 10, 2025 | Tuesday | News
Addex Therapeutics Reports Strong Preclinical Efficacy of GABAB Modulator for Chronic Cough

Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule all...

June 10, 2025 | Tuesday | News
Regeneron and Sanofi’s Dupixent Shows Strong Efficacy in Atopic Dermatitis Patients With Skin of Color

Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved 75% or greater improvement in overall dise...

June 09, 2025 | Monday | News
ByteBrain Launches MEDRAIL to Transform Clinical Trials with AI-Powered Compliance and Safety Automation

ByteBrain LLC, an emerging AI research and consulting firm, has announced the launch of MEDRAIL, an intelligent platform designed to help pharmaceutical co...

June 06, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close